| Members |
targetComponentId |
| har inte fått MMR-vaccination |
Measles mumps and rubella vaccination not done (situation) |
| mupirocinkalcium 2 %, kräm |
Mupirocin (as mupirocin calcium) 20 mg/mL cutaneous cream |
| Mural cardiac aneurysm |
Aneurysm of heart |
| muralt hjärtaneurysm |
Aneurysm of heart |
| muskeltransposition för operation av klotå |
Transfer of flexor to extensor tendon of lesser toe |
| Muscular calcification |
Muscular ossification |
| Muscular wasting and disuse atrophy, NEC |
Muscle atrophy |
| Musculoskel X-ray abnorm [D] |
X-ray of musculoskeletal system abnormal |
| Mushroom |
Order Agaricales |
| svamp, livsmedel |
Mushroom (substance) |
| senap, livsmedel |
Mustard seasoning (substance) |
| Mutase |
Mutase |
| Mycobacterium aquae |
Mycobacterium gordonae |
| Mycobacterium bolletii |
Mycobacteroides abscessus subspecies abscessus (organism) |
| Mycobacterium chelonae ss. abscessus |
Mycobacteroides abscessus (organism) |
| Mycobacterium chelonae ss. chelonae |
Mycobacteroides chelonae |
| Mycobacterium chlorophenolicus |
Mycobacterium chlorophenolicum |
| Mycobacterium mageritense |
Mycobacterium mageritense (organism) |
| Mycobacterium, MAIS group |
Mycobacterium, avium-intracellulare group |
| mykofenolsyra 180 mg, kapsel med modifierad frisättning |
Mycophenolic acid (as mycophenolate sodium) 180 mg gastro-resistant oral tablet |
| mykofenolsyra 360 mg, kapsel med modifierad frisättning |
Mycophenolic acid (as mycophenolate sodium) 360 mg gastro-resistant oral tablet |
| Mycoplana bullata |
Brevundimonas bullata (organism) |
| Mycoplasma ellychniae |
Entomoplasma ellychniae |
| Mycoplasma lactucae |
Mesoplasma lactucae |
| Mycoplasma lepcaptivus |
Mycoplasma leonicaptivi (organism) |
| Mycoplasma lucivorax |
Entomoplasma lucivorax |
| Mycoplasma melaleucae |
Entomoplasma melaleucae |
| Mycoplasma somnilux |
Entomoplasma somnilux |
| Mycoplasma weynonii |
Mycoplasma wenyonii (organism) |
| Mycosis leptothrica |
Tonsillitis due to Gram negative bacteria |
| mykotiskt aneurysm orsakat av bakteriell endokardit |
Endocarditis with infective aneurysm |
| Myelodysplasia |
Myelodysplasia of spinal cord |
| myeloisk leukemi, kategori |
Myeloid leukaemia |
| myeloisk leukemi |
Myeloid leukaemia |
| myeloproliferativ sjukdom |
Myeloproliferative disorder (morphologic abnormality) |
| Myelosclerosis |
Myelofibrosis |
| Myelosclerosis with myeloid metaplasia |
Myelosclerosis with myeloid metaplasia |
| klinisk handläggningsplan för hjärtinfarkt |
Myocardial infarction clinical management plan (record artifact) |
| myom |
Myoma |
| Myotenontoplasty |
Myotenoplasty |
| Myotenoplasty of hand |
Myotenoplasty |
| muskeltensionsteknik |
Muscle energy technique (procedure) |
| Myovirus group |
Family Myoviridae (organism) |
| NAD(P)H dehydrogenase (FMN) |
NAD(P)H dehydrogenase (quinone) |
| Nabothian follicles on cervix |
Mucous retention cyst of cervix uteri (disorder) |
| ovula Nabothi på livmoderhals |
Mucous retention cyst of cervix uteri (disorder) |
| Nabothian follicles on cervix |
Mucous retention cyst of cervix uteri (disorder) |
| nabumeton 500 mg, dispergerbar tablett |
Nabumetone 2.5 mg/mL oral solution |
| Nairobi sheep disease serogroup |
Nairobi sheep disease virus |
| nafazolinhydroklorid 0,02 % + polyvinylalkohol 0,25 % + zinksulfat 0,25 %, vikt per volym, droppar |
Product containing only naphazoline and polyvinyl alcohol and zinc sulfate (medicinal product) |
| naproxen 200 mg + pseudoefedrin 120 mg, tablett med modifierad frisättning |
Product containing only naproxen and pseudoephedrine (medicinal product) |
| naproxennatrium 200 mg + pseudoefedrin 120 mg, depåtablett |
Product containing only naproxen and pseudoephedrine (medicinal product) |
| naproxennatrium 220 mg + pseudoefedrin 120 mg, tablett med modifierad frisättning |
Product containing only naproxen and pseudoephedrine (medicinal product) |
| naproxennatrium 220 mg + pseudoefedrin 120 mg, depåtablett |
Product containing only naproxen and pseudoephedrine (medicinal product) |
| naproxennatrium 375 mg, enterotablett |
Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
| naproxennatrium 375 mg, tablett med modifierad frisättning |
Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
| naproxennatrium 500 mg, enterotablett |
Naproxen only product in oral dose form |
| naproxennatrium 500 mg, tablett med modifierad frisättning |
Naproxen only product in oral dose form |
| Narrow open angle |
Narrow angle (finding) |
| Nausea |
Nausea (finding) |
| Near complete invasion of mesorectum by tumor |
Mesorectal specimen nearly completely intact (finding) |
| Neck of other metacarpal |
Neck of metacarpal bone structure (body structure) |
| tvåfragmentsfraktur enligt Neer |
Neer two-part fracture |
| trefragmentsfraktur enligt Neer |
Neer three-part fracture |
| fyrfragmentsfraktur enligt Neer |
Neer four-part fracture |
| Negroid nose |
Nose finding |
| Neisseria meningitidis group Z' |
Neisseria meningitidis serogroup Z (organism) |
| neomycinsulfat 0,5 %, ögondroppar |
Product containing only neomycin in ocular dose form (medicinal product form) |
| neomycinsulfat 0,5 %, ögondroppar för engångsbruk |
Product containing only neomycin in ocular dose form (medicinal product form) |
| neomycinsulfatallergi |
Allergy to neomycin (finding) |
| neomycin + hydrokortison 0,5 %/1,5 %, örondroppar |
Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution |
| Neonatal calf diarrhea coronavirus |
Bovine coronavirus (organism) |
| Neonatal candida infection |
Neonatal candidiasis (disorder) |
| Neonatal candidiasis of mouth |
Neonatal candidiasis (disorder) |
| neonatal tarmperforation med medfödd stenos i tarmkanalen |
Neonatal perforation of intestine due to congenital stenosis of intestine |
| Neonatal monilia infection |
Neonatal candidiasis (disorder) |
| Neonatal thrombocytopenia due to isoimmunization |
Transient neonatal thrombocytopenia |
| Neophema bourkii |
Neopsephotus bourkii (organism) |
| tumör, indelning efter lokalisation |
Neoplastic disease |
| tumör av perivaskulär myoid typ, kategori |
Perivascular myoid neoplasm (morphologic abnormality) |
| Neoplastic process |
Neoplasm |
| neotran |
Bis-(p-chlorophenoxy) methane |
| Neovascularization of iris AND/OR ciliary body |
Disorder of uveal tract |
| Nephrogenic diabetes insipidus |
Nephrogenic diabetes insipidus |
| Nephrolithiasis |
Kidney stone |
| Nerve bundle |
Central nervous system tract structure |
| Nerve conduction deafness |
Neural hearing loss |
| nervskidetumör |
Benign nerve sheath tumor |
| Nesochen sandvicensis |
Branta sandvicensis (organism) |
| Nettle rash |
Urticaria |
| Neuralgia |
Neuralgia |
| neurinomatos |
Melanotic schwannoma |
| neurokutan melanos |
Neurocutaneous melanosis |
| neuroektodermalt endokrint syndrom |
Woodhouse Sakati syndrome |
| neurofibramatos 3 |
Schwannomatosis |
| neurofibrom |
Benign neurofibroma |
| neurofibromatos typ 3 |
Schwannomatosis |
| Neuroleptic malignant syndrome |
Neuroleptic malignant syndrome |
| Neurologic myelopathy-retired |
Spinal cord disorder (disorder) |
| Neurological status not worse than preoperative baseline |
Neurological status is consistent with or improved from preoperative baseline (finding) |
| Neurolysis - action |
Destruction - action |
FHIR